Richard Pazdur
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Richard Pazdur
May 7, 2024, 15:45 |
Blog
FDA Oncology's Project 5 in 5
Kelly Norsworthy, Deputy Division Director, Division of Hematologic Malignancies 1 at Johns Hopkins University, shared a…
Apr 25, 2024, 12:59 |
Societies
Chitkala Kalidas: It was a pleasure participating in the industry panel discussion at Cancer Drug Development Forum
Chitkala Kalidas, Vice President, Global Head of Oncology at Bayer shared a post on LinkedIn:…
Feb 23, 2024, 11:08 |
Insight
Provides an overview of oncology drugs approved the previous year - Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology shared a post on X: "One more year FDA Oncology provides an…
Jun 7, 2023, 03:37 |
Drugs
Addressing Cisplatin and Carboplatin Shortages: Insights from FDA Oncology Center of Excellence Director
In this open access discussion, Richard Pazdur, Director of the FDA Oncology Center of Excellence,…
All:
4
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube